Medtronic announced a strategic partnership with Cornerstone Robotics, a surgical robotics company. The approximately $700 million investment includes rights to distribute Cornerstone Robotics' Sentire surgical system in select markets outside the U.S. where the system is market approved.
Medtronic will distribute Sentire alongside its Hugo robotic-assisted surgery (RAS) system.
The company said the partnership builds on the momentum of its Hugo RAS system, which is now being used in more than 35 countries including the United States, where it received FDA clearance within the last year. The modular, multi-quadrant platform is designed for a range of soft-tissue surgical procedures and combines wristed instruments, 3D visualization and Touch Surgery ecosystem with dedicated support for robotics program optimization, service and training.
The Sentire system's architecture and console with dual-console capability offer a configuration suited to varying surgeon preferences and clinical needs. Developed entirely in-house by Cornerstone Robotics, Sentire has completed multi-specialty clinical trials and received CE Mark in May 2026 for use in minimally invasive general, gynecologic, thoracic, and urologic surgical procedures in addition to its market approval in China and Singapore.
